David O. Watson, General Counsel at Apellis Pharmaceuticals, Inc. (APLS), sold 5,000 shares at $34.24 ($171K) on 2024-12-11, disclosed to the SEC on 2024-12-13.
Open-market sale of $171k APLS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APLS | SELL | 2026-01-15 | $128K | — | Filing → |
| APLS | SELL | 2025-12-18 | $245K | — | Filing → |
| APLS | SELL | 2025-11-18 | $100K | — | Filing → |